6533b7cffe1ef96bd1259098

RESEARCH PRODUCT

Stage-specific chromosomal association of Drosophila dMBD2/3 during genome activation.

Esteban BallestarDirk Henner LankenauDaniel W. GerlichMingfa LiJoachim MarholdMarcin ZbylutBernard M. MechlerFrank Lyko

subject

MaleImmunoblottingBiologyY chromosomeGenomeChromosomesSpermatocytesY ChromosomeGeneticsAnimalsDrosophila ProteinsEpigeneticsGeneGenetics (clinical)Regulation of gene expressionMicroscopy ConfocalGene Expression Regulation DevelopmentalMolecular biologyChromatinCell biologyDNA-Binding ProteinsCytoplasmDrosophilaFemaleBlastodermProtein Binding

description

The Drosophila gene dMBD2/3 encodes a protein with significant homologies to the mammalian methyl-DNA binding proteins MBD2 and MBD3. These proteins are essential components of chromatin complexes involved in epigenetic gene regulation. Because the available in vitro data on dMBD2/3 are conflicting we have started an in vivo characterization of dMBD2/3. We detected expression of two isoforms specifically during embryonic development. Staining of whole embryos combined with high-resolution confocal microscopy revealed a highly regulated spatial distribution. During the syncytial blastoderm stage, dMBD2/3 formed speckles that localized to the cytoplasm. Shortly after, during the cellular blastoderm stage, the protein entered the nucleus and formed bright foci that associated with DNA. This rapid transition coincided with the activation of the embryonic genome. A similar observation was made during activation of the spermatocyte genome as dMBD2/3 formed distinct foci associated with the activated Y chromosome. Our results indicate that dMBD2/3 forms specialized nuclear compartments to keep certain genes epigenetically silenced during genome activation.

10.1007/s00412-002-0188-2https://pubmed.ncbi.nlm.nih.gov/12068919